REQUEST A DEMO
Total
USD $0.00
Search more companies

Tech Pharmaceutical S.A.S (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Tech Pharmaceutical S.A.S Profile Updated: April 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Tech Pharmaceutical S.A.S is based in Colombia, with the head office in Tocancipa. It operates in the Pharmaceutical Preparation Manufacturing industry. The company was established on March 12, 2004. 1 (2023) employees currently work for Tech Pharmaceutical S.A.S. Its’ total assets recorded a negative growth of 51.92%.

Headquarters
Parque Industrial Gran Sabana Unidad Privada # 28
Tocancipa; Cundinamarca;

Contact Details: Purchase the Tech Pharmaceutical S.A.S report to view the information.

Basic Information
Total Employees:
Purchase the Tech Pharmaceutical S.A.S report to view the information.
Financial Auditors:
Purchase the Tech Pharmaceutical S.A.S report to view the information.
Incorporation Date:
March 12, 2004
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Tech Pharmaceutical S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
73.77%
Net Profit (Loss) for the Period
74.92%
Total assets
-51.92%
Total equity
-9.17%
Return on Equity (ROE)
26.48%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?